Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
about
The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation.Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.Sofosbuvir and daclatasvir.Serum amyloid a induces M2b-like macrophage polarization during liver inflammation.The Initiation Factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G Are Not Involved in Translation Driven by Hepatitis C Virus IRES in Human Cells.Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
P2860
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@ast
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@en
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@nl
type
label
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@ast
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@en
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@nl
prefLabel
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@ast
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@en
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@nl
P2860
P3181
P356
P1476
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment
@en
P2093
Roberto J Firpi
Vikas Khullar
P2860
P304
P3181
P356
10.4254/WJH.V7.I14.1843
P407
P577
2015-07-18T00:00:00Z